Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, May 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 1 X user

wikipedia: 4 Wikipedia pages

Citations

dimensions_citation: 84 Dimensions

Readers on

mendeley: 129 Mendeley

Summary X Wikipedia Dimensions citations

So far, Dimensions has found 84 publications that cite this research output.

84

The most recent citing publications are shown below. View all 84 publications that cite this research output on Dimensions.

Synthesis and clinical application of representative small-molecule dipeptidyl Peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus (T2DM)

Article in European Journal of Medicinal Chemistry (May 2024)

Novel UV Spectrophotometric approaches for the concurrent determination of Teneligliptin and Metformin in Tablet Formulation

Article in Research Journal of Pharmacy and Technology (March 2024)

In silico modified UV spectrophotometric approaches to resolve overlapped spectra for quality control of rosuvastatin and teneligliptin formulation

Article in Open Physics (January 2024)